Based on age, we classified eyes with diffractive multifocal IOL into four groups: u50 (under 50 years old), 50s (50–59 years), 60s, and 70s. Corrected distance (CD), distance-corrected near (DCN) ...

To evaluate the postoperative outcomes of cataract eyes complicated with coexisting ocular pathologies that underwent implantation of a refractive multifocal intraocular lens (MIOL) with a ...

Corneal refractive surgery has been performed on millions of patients to decrease their spectacle dependence. Most of these patients have high expectations of visual function—but as these patients age ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — Adding a toric platform to a multifocal IOL significantly improves vision at intermediate and near ...

After bilateral cataract surgery, patients implanted with multifocal intraocular lenses (IOLs) were more likely to be spectacle-independent but also to undergo IOL exchange than those with monofocal ...

Combining an aspheric multifocal IOL with wavefront-guided LASIK can provide good near and distance vision for presbyopic hyperopic patients, according to one investigator. Michael C. Knorz, MD, of ...

Multifocal lenses use multiple refractive zones built in rings to give patients distance and near vision. These lenses are designed to address the problem of presbyopia, in which people over the age ...

Two new intraocular lenses (IOLs) that restore vision to people with cataracts are now available in the United States. The new TECNIS ® Multifocal IOLs, developed by Abbott (NYSE: ABT), provide people ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--The company Swiss Advanced Vision (SAV-IOL SA) announced today the launch of LUCIDIS and EDEN, two new intraocular lenses (IOLs) for the cataract surgery, both ...

The eye's natural crystalline lens can be replaced with an artificial lens—known as an intraocular lens—to restore clarity and lead to a vast improvement in quality of life for patients with cataracts ...

VAUGHAN, Ontario--(BUSINESS WIRE)-- Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S.